Valuation: Janel Corporation

Market Cap 56.94M 51.09M 47.24M 42.78M 79.92M 5.42B 80.89M 565M 225M 2.84B 214M 209M 9.01B P/E 2024
225x
P/E 2025 8.64x
Enterprise Value 64.56M 57.92M 53.55M 48.5M 90.61M 6.15B 91.71M 640M 255M 3.22B 242M 237M 10.21B EV / Sales 2024
0.46x
EV / Sales 2025 0.24x
Free-Float
17.04%
Yield 2024 *
-
Yield 2025 -
1 day-2.04%
3 months-17.24%
6 months-7.21%
Current year+20.00%
1 month 45
Extreme 45
51.1
Current year 37
Extreme 37
58
1 year 21
Extreme 21
58
3 years 21
Extreme 21
58
5 years 15.51
Extreme 15.51
62
10 years 4.01
Extreme 4.01
62
Manager TitleAgeSince
Chief Executive Officer 52 01/01/2023
Director of Finance/CFO 39 02/08/2025
Chief Executive Officer 52 11/09/2014
Director TitleAgeSince
Director/Board Member 77 18/11/2015
Director/Board Member 76 01/06/2016
Director/Board Member 74 02/01/2018
Date Insider Type Main position Quantity % Market Cap. Importance
10/1/26 A Free

Director

2,500 0.2108%
10/1/26 A Free

Director

2,500 0.2108%
10/1/26 A Free

Director

2,500 0.2108%
Change 5-day change 1-year change 3-year change Capi.($)
-2.04%0.00%+33.30%+88.24% 56.94M
+0.50%+1.38%+57.09%+129.96% 1,143B
+0.86%+5.14%+45.00%+86.15% 647B
-0.14%+0.42%+25.69%+105.85% 506B
-0.05%+1.73%+52.74%+67.74% 384B
-0.63%-5.97%+61.93%+37.06% 350B
+0.34%+1.84%+30.70%+54.27% 293B
-0.45%+1.19%+2.89%+26.08% 265B
+0.87%+3.08%+54.69%+72.74% 242B
+0.08%+3.67%+35.05%+107.78% 197B
Average -0.07%+1.30%+39.91%+77.59% 402.76B
Weighted average by Cap. +0.25%+1.55%+44.50%+89.02%

Financials

2024 2025
Net sales 183M 164M 152M 138M 257M 17.45B 260M 1.82B 724M 9.13B 687M 673M 28.98B 207M 186M 172M 156M 291M 19.76B 295M 2.06B 819M 10.34B 778M 762M 32.82B
Net income 551K 494K 457K 414K 773K 52.48M 783K 5.46M 2.18M 27.46M 2.07M 2.02M 87.18M 5.66M 5.08M 4.69M 4.25M 7.94M 539M 8.04M 56.1M 22.35M 282M 21.23M 20.78M 895M
Net Debt 36.99M 33.19M 30.68M 27.79M 51.91M 3.52B 52.54M 367M 146M 1.84B 139M 136M 5.85B 7.62M 6.83M 6.32M 5.72M 10.69M 725M 10.82M 75.53M 30.09M 380M 28.58M 27.98M 1.2B
Projected Income Statement - Annual - Janel Corporation
Logo Janel Corporation
Janel Corporation is a holding company with subsidiaries in three business segments: Logistics, Life Sciences and Manufacturing. The Company’s Life Sciences segment comprises several wholly owned subsidiaries. The Company’s Life Sciences segment manufactures and distributes monoclonal and polyclonal antibodies, diagnostic reagents and other immunoreagents for biomedical research and provides antibody manufacturing for academic and industry research scientists. The Company’s Manufacturing segment comprises Indco, Inc. (Indco). Indco is a majority-owned subsidiary of the Company that manufactures and distributes mixing equipment and apparatus for specific applications within various industries. Its Logistics segment is a non-asset based, full-service provider of cargo transportation logistics management services including freight forwarding via air, ocean and land-based carriers; customs brokerage services; warehousing and distribution services; trucking and others.
Employees
353
Date Price Change Volume
21/10/26 $48.00 -2.04% 100
  1. Stock Market
  2. Stocks
  3. JANL Stock